Multicentre, double-blind, randomised, placebo-controlled phase Ia escalating single dose study to evaluate the tolerability and pharmacokinetics of AEOL 10150 in patients with amyotrophic lateral sclerosis
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2010
At a glance
- Drugs AEOL 10150 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions; Pharmacokinetics
- 05 Nov 2010 New trial record.
- 07 Sep 2005 Results published in an Aeolus Pharmaceuticals Inc media release.